Xylometazoline + Ipratropium Bromide Nasal Spray
Xylometazoline + Ipratropium Bromide Nasal Spray
Xylometazoline + Ipratropium Bromide — PCD Pharma Franchise, Wholesale Supply & Third Party Manufacturing
Form: Nasal Spray
Class: Fixed-Dose Combination — Nasal decongestant + Short-acting anticholinergic bronchodilator
✓ Pan-India Monopoly PCD
✓ Available Now
Pricing, brochure & monopoly territory within 24 hrs.
Xylometazoline + Ipratropium Bromide Nasal Spray is manufactured and supplied by Trumac Healthcare, a WHO-GMP certified pharmaceutical company in India. This nasal spray is available for monopoly PCD pharma franchise, wholesale and distributor supply, and third party / contract manufacturing across all Indian states.
Therapeutic Indications
- Nasal congestion due to common cold
- Blocked nose in allergic or vasomotor rhinitis
- Bronchospasm in chronic obstructive pulmonary disease (COPD)
- Asthma, as add-on to beta-agonists
Mechanism of Action
Xylometazoline — Xylometazoline stimulates alpha-adrenergic receptors on blood vessels in the nasal lining, causing them to constrict. This shrinks swollen nasal tissue, opening the nasal passages within minutes and relieving congestion for several hours.
Ipratropium Bromide — Ipratropium blocks muscarinic receptors in airway smooth muscle, preventing acetylcholine-induced bronchoconstriction. Combined with salbutamol, it adds bronchodilation through a complementary mechanism.
Combining these ingredients in one nasal spray provides complementary action on the target condition and simplifies therapy compared with taking the components separately.
Dosage & Administration
- Apply or instil Xylometazoline + Ipratropium Bromide Nasal Spray exactly as directed by the treating physician; frequency and duration depend on the condition treated.
- Use only by the labelled route; avoid touching the dropper or nozzle tip to any surface.
- Wash hands before and after use unless the hands are the treated area.
- Stop use and consult a doctor if irritation, rash or swelling develops.
Side Effects
- Nasal burning, stinging or dryness
- Sneezing
- Headache
- Dry mouth
- Throat irritation and cough
Contraindications
- Known hypersensitivity to any component of the formulation
- Short-term use only; prolonged use causes rebound congestion
- Not for infants; children only with paediatric strength on advice
- Hypersensitivity to atropine or its derivatives
- Narrow-angle glaucoma: avoid spraying into the eyes
Storage
Store below 30 °C in a dry place, protected from light and moisture. Keep in the original packaging until use. Keep out of reach of children. Dispense strictly on a registered medical practitioner's prescription.
PCD Pharma Franchise & Third Party Manufacturing — Xylometazoline + Ipratropium Bromide Nasal Spray
- ✓ WHO-GMP certified manufacturing — every batch QC released
- ✓ Monopoly PCD franchise rights at district or state level
- ✓ Third party / contract manufacturing under your own brand
- ✓ Wholesale and distributor supply against drug licence + GST
- ✓ Attractive net rates with healthy PTR / PTS margins
- ✓ Dispatch within 48 hours of payment realisation
Composition: Xylometazoline + Ipratropium Bromide. It is a fixed-dose combination of nasal decongestant and short-acting anticholinergic bronchodilator, used for nasal congestion due to common cold and bronchospasm in chronic obstructive pulmonary disease (COPD). Trumac Healthcare supplies it with complete quality documentation — batch Certificate of Analysis, GMP certificate and statutory invoicing — to PCD franchise partners, stockists, wholesalers and hospital supply chains nationwide.
Xylometazoline + Ipratropium Bromide Nasal Spray brings together Xylometazoline (nasal decongestant) and Ipratropium Bromide (short-acting anticholinergic bronchodilator) in a single fixed-dose formulation.
PCD franchise partners receive monopoly territory rights at district or state level, promotional support including visual aids and sample literature, competitive net rates with healthy PTR/PTS margins, and dispatch within 48 hours of payment realisation. Third party manufacturing of Xylometazoline + Ipratropium Bromide Nasal Spray under your own brand name is available subject to minimum order quantity and valid drug licence and GST documentation.
Frequently Asked Questions
Who manufactures Xylometazoline + Ipratropium Bromide Nasal Spray in India?
Trumac Healthcare is a WHO-GMP certified manufacturer and supplier of Xylometazoline + Ipratropium Bromide Nasal Spray in India. We supply pan-India to PCD franchise partners, wholesalers, distributors and hospital chains, with full QC documentation and batch Certificate of Analysis. Contact +91 90416 77932 for net rates and availability.
What is Xylometazoline + Ipratropium Bromide Nasal Spray used for?
Xylometazoline + Ipratropium Bromide Nasal Spray is used for nasal congestion due to common cold; blocked nose in allergic or vasomotor rhinitis; bronchospasm in chronic obstructive pulmonary disease (COPD); asthma, as add-on to beta-agonists. It should be used as advised by a registered medical practitioner.
Is Xylometazoline + Ipratropium Bromide Nasal Spray available for PCD pharma franchise on monopoly basis?
Yes. Xylometazoline + Ipratropium Bromide Nasal Spray is available for monopoly PCD (Propaganda Cum Distribution) pharma franchise across India, with monopoly rights granted at district or state level. Franchise partners receive promotional support, territory protection, competitive net rates with healthy PTR/PTS margins and dedicated backend support.
Do you offer Xylometazoline + Ipratropium Bromide for third party or contract manufacturing?
Yes. Trumac Healthcare undertakes third party manufacturing and contract manufacturing of Xylometazoline + Ipratropium Bromide Nasal Spray under your own brand name, subject to minimum order quantity and valid drug licence and GST documentation. Custom pack sizes, carton design and artwork are supported.
Can Xylometazoline + Ipratropium Bromide Nasal Spray be supplied on wholesale or distributor basis?
Yes. Beyond PCD franchise, this product is supplied to wholesalers, stockists and distributors at wholesale rates against a valid drug licence and GST registration. Bulk and institutional supply is available on request.
What is the therapeutic class of Xylometazoline + Ipratropium Bromide?
Xylometazoline + Ipratropium Bromide is a fixed-dose combination of nasal decongestant and short-acting anticholinergic bronchodilator (therapeutic class: Fixed-Dose Combination — Nasal decongestant + Short-acting anticholinergic bronchodilator).
What documentation is provided with each supply?
Every batch ships with a Certificate of Analysis (COA), GMP certificate, drug licence copies and statutory invoice. We also support PCD partner documentation including monopoly agreement, rate contract and product list.
How quickly can an order be dispatched?
Routine PCD orders are dispatched within 48 hours of payment realisation, subject to stock availability and your distance from our depot. For monopoly partners we maintain buffer stock against forecasted monthly off-take.
Is a prescription required for Xylometazoline + Ipratropium Bromide Nasal Spray?
Yes. This is a prescription medicine and must be used strictly under the supervision of a registered medical practitioner. PCD franchise distribution is through licensed retail pharmacies and hospital supply chains only.
Ready to start your PCD franchise for Xylometazoline + Ipratropium Bromide Nasal Spray?